CymaBay Therapeutics, Inc.

GOLDMAN SACHS GROUP INC

Report date

12/31/2023

Quarter

2023 Q4

Filed

5/14/2024

Shares

630,735

Value ($000)

14,898

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	5/14/2024	14,898	0.0%	630,735	12/31/2023
2023 Q3	5/15/2024	8,361	0.0%	560,761	9/30/2023
2023 Q2	5/14/2024	6,276	0.0%	573,145	6/30/2023
2023 Q1	5/14/2024	6,744	0.0%	773,346	3/31/2023
2022 Q4	5/14/2024	534	0.0%	85,214	12/31/2022
2022 Q3	5/14/2024	822	0.0%	234,722	9/30/2022
2022 Q2	5/14/2024	753	0.0%	255,043	6/30/2022
2022 Q1	5/16/2022	1,754	0.0%	564,116	3/31/2022
2021 Q4	2/17/2022	1,444	0.0%	427,120	12/31/2021
2021 Q3	1/20/2022	522	0.0%	142,964	9/30/2021
2021 Q2	8/13/2021	621	0.0%	142,363	6/30/2021
2021 Q1	5/17/2021	421	0.0%	92,768	3/31/2021
2020 Q4	2/12/2021	5,401	0.0%	940,982	12/31/2020
2020 Q3	11/13/2020	655	0.0%	90,578	9/30/2020
2020 Q2	8/12/2020	2,496	0.0%	714,975	6/30/2020
2020 Q1	5/15/2020	1,070	0.0%	722,501	3/31/2020
2019 Q4	2/14/2020	746	0.0%	380,401	12/31/2019